Treatment of Advanced Seminoma with Chemotherapy
Author Information
Author(s): M.J. Peckham, A. Horwich, W.F. Hendry
Primary Institution: The Royal Marsden Hospital
Hypothesis
Can cis-platinum-based combination chemotherapy or carboplatin effectively treat advanced seminoma?
Conclusion
The study found that 90% of patients with advanced seminoma are alive and disease-free after treatment with chemotherapy.
Supporting Evidence
- 90% of patients treated with chemotherapy are alive and disease-free.
- Residual masses were present in almost 80% of patients one month after chemotherapy.
- Relapse rates were similar in patients who received radiotherapy and those who did not.
Takeaway
Most patients with advanced seminoma can be treated successfully with chemotherapy, and many do not need surgery afterward.
Methodology
Patients were treated with either cis-platinum-based combination chemotherapy or carboplatin, and their outcomes were assessed over a median follow-up of 36 months.
Limitations
The study did not include patients who had received prior chemotherapy, and the follow-up times varied among patients.
Participant Demographics
Patients aged 23 to 56 years, with a mix of primary intra-scrotal and mediastinal seminomas.
Statistical Information
P-Value
p=0.03
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website